AQUINO JARQUIN, GUILLERMO

AQUINO JARQUIN, GUILLERMO

BIOLOGÍA Y QUÍMICA · Nivel 2

CRISPR-Cas technology Genome editing Gene regulation Non-coding RNAs

Desde 2009 es Researcher in Medical Sciences en Hospital Infantil de México Federico Gómez

Dr. Aquino is an established biomedical research scientist in the RNA Biology and Genome Editing Section at the Children’s Hospital of Mexico "Federico Gómez" in Mexico City. Dr. Aquino’s research interests include improving our understanding of the role of non-coding...

Dr. Aquino is an established biomedical research scientist in the RNA Biology and Genome Editing Section at the Children’s Hospital of Mexico "Federico Gómez" in Mexico City. Dr. Aquino’s research interests include improving our understanding of the role of non-coding transcripts in regulating gene expression in human cells by employing CRISPR-Cas technology. Furthermore, he is developing a microRNA detection/quantification system based on the CRISPR-Cas13 system. Dr. Aquino is also keen on establishing guidelines for CRISPR applications in accordance with international regulations for gene editing at the Children's Hospital of Mexico. He contributes to teaching advanced molecular biology at the National Autonomous University of Mexico (UNAM) and mentoring students from the Master’s and doctoral programs in Biological Sciences at the UNAM.

Leer más

Perfil académico

Nombre GUILLERMO AQUINO JARQUIN
Área BIOLOGÍA Y QUÍMICA
Campo BIOLOGÍA Y QUÍMICA
Disciplina BIOLOGÍA MOLECULAR
Especialidad BIOLOGIA MOLECULAR
CVU 42964
Institución
Dependencia SUBDIRECCION DE INVESTIGACION
Entidad CIUDAD DE MEXICO
Nivel 2
Vigencia Inicio: 01/01/2025
Fin: 31/12/2029

Últimas publicaciones Scopus

2026
Preventable mortality in Mexico: bridging gaps in chronic disease and ageing care BMJ Global Health · Vol. 11 Review
Beyond statutory compliance: toward comprehensive genomic governance Trends in Biotechnology Letter
The oriGen case and Mexico's regulatory blind spots in genomic biobanking Trends in Biotechnology Short Survey
Emerging cell surface glycoRNAs with potential regulatory roles Drug Discovery Today · Vol. 31 Review
2025
The roles and perspectives of YY1 in immune central tolerance establishment Biochimica Et Biophysica Acta Reviews on Cancer · Vol. 1880 Review